Mark Alan Goldberg's Net Worth
Mark Alan Goldberg's net worth is estimated to be at least $2,419,318.69 as of 05/09/2024. CoreStreet's estimation of Mark Alan Goldberg's net worth is based on their sale of stock and current holding of stock.
Mark Alan Goldberg is Director at Blueprint Medicines Corp. They have executed at least 8 trades of stock as per SEC Form 4 filings. Their most recent trade was for 5,000 units of BPMC stock on 03/03/2022. Their biggest sale was on 12/24/2020 when they sold 5,455 units of Blueprint Medicines Corp stock for $681,875.00. They typically trade 1 times per year.
Total value of insider buys:
- $592,103.69
Total value of insider sells:
- $1,827,215.00
Most recent insider trade:
- March 3, 2022
Mark Alan Goldberg's Insider Trading History
| Blueprint Medicines Corp | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
March 3, 2022 | Director | 5,000 | $59.98 | Buy | $299,900.00 |
Dec. 24, 2020 | Director | 5,455 | $125.00 | Sell | $681,875.00 |
Dec. 1, 2020 | Director | 5,454 | $110.00 | Sell | $599,940.00 |
Oct. 7, 2020 | Director | 5,454 | $100.00 | Sell | $545,400.00 |
| ImmunoGen Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Nov. 6, 2018 | Director | 30,000 | $5.76 | Buy | $172,800.00 |
Dec. 15, 2016 | Director | 20,000 | $1.80 | Buy | $36,000.00 |
Nov. 8, 2012 | Director | 3,000 | $11.27 | Buy | $33,810.00 |
| GlycoMimetics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
March 4, 2016 | Director | 10,397 | $4.77 | Buy | $49,593.69 |